CPT® Code 87621

Deleted

1. Indications

The procedure associated with CPT® Code 87621 is indicated for the detection of human papillomavirus (HPV) in patients who may be at risk for HPV-related diseases. The following conditions warrant the use of this test:

• Screening for HPV: This test is used to screen individuals, particularly women, for the presence of high-risk HPV types that are associated with cervical cancer.
• Diagnosis of HPV-related conditions: It aids in diagnosing conditions related to HPV infection, including genital warts and precancerous lesions.
• Monitoring treatment response: The test can be utilized to monitor the effectiveness of treatment in patients previously diagnosed with HPV-related diseases.
• Assessment of risk: It is indicated for individuals with abnormal Pap test results to assess the risk of developing cervical cancer.

2. Procedure

The procedure for CPT® Code 87621 involves several critical steps to ensure accurate detection of HPV nucleic acids. The following procedural steps are outlined:

• Specimen Collection: The first step involves the collection of a specimen, which may include scrapings from the cervix, vagina, male urethra, or anus. This is typically performed by a healthcare professional using appropriate techniques to ensure the integrity of the sample.
• Preparation of the Specimen: Once collected, the specimen is prepared for testing. This may involve lysing the cells to release nucleic acids, which is essential for the subsequent amplification and detection processes.
• Amplification of Nucleic Acids: The next step employs an amplification technique, such as polymerase chain reaction (PCR) or transcription-mediated amplification (TMA). This process creates multiple copies of the specific HPV nucleic acids present in the specimen, which is crucial for detecting low levels of the virus.
• Detection of HPV Nucleic Acids: After amplification, the specific HPV nucleic acids are detected using various techniques. This step is vital for confirming the presence of the virus and identifying the specific types that may be present.

3. Post-Procedure

Post-procedure care for patients undergoing testing with CPT® Code 87621 typically involves providing the patient with information regarding the test results and any necessary follow-up actions. Patients may be advised to schedule a follow-up appointment to discuss the results, especially if high-risk HPV types are detected. Additionally, healthcare providers may recommend further diagnostic procedures or treatments based on the findings. It is important for patients to understand the implications of their test results, including the potential need for additional monitoring or interventions related to HPV-related conditions.